Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.04 AUD | -2.21% | +0.47% | +49.21% |
05-03 | Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP | MT |
04-30 | Bell Potter Downgrades Telix Pharmaceuticals to Hold from Buy, Price Target is AU$14.50 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.21% | 3.36B | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+44.53% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- TLX Stock
- News Telix Pharmaceuticals Limited
- Telix Pharmaceuticals to Acquire QSAM Biosciences, CycloSam Lead Therapy